Human recombinant interferon alpha-2a (r IFN alpha-2a) therapy suppresses hepatic triglyceride lipase, leading to severe hypertriglyceridemia in a diabetic patient.

Sorry, there's nothing here.

Cite this paper

@article{Yamagishi1994HumanRI, title={Human recombinant interferon alpha-2a (r IFN alpha-2a) therapy suppresses hepatic triglyceride lipase, leading to severe hypertriglyceridemia in a diabetic patient.}, author={Sho-ichi Yamagishi and Toshiaki Abe and Tatsuo Sawada}, journal={The American journal of gastroenterology}, year={1994}, volume={89 12}, pages={2280} }